<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Naylor-Adamson L</submitter><funding>British Heart Foundation</funding><funding>Medical Research Council</funding><pagination>1052-1063</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11619005</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>13(3)</volume><pubmed_abstract>Quantum dots (QDs) are semiconducting inorganic nanocrystals, that have garnered interest in biological and medical spheres due, to their potential benefits in biomedical imaging and drug-delivery systems. Indium phosphide QDs shelled with zinc sulphide (InP/ZnS) are viewed as more biocompatible than previous heavy metal based QDs. However, little is known about how InP/ZnS QDs affect a key blood cell, the platelet. Understanding how platelets interact with QDs is critical as unwanted activation can lead to pathological thrombus formation. Herein, we demonstrate PEGylation of InP/ZnS QDs coated with lipoic acid (QD-LA) or coated with penicillamine (QD-Pen) surface ligands induced markedly less platelet aggregation, platelet-QD interactions, integrin activation, alpha granule secretion and </pubmed_abstract><journal>Journal of materials chemistry. B</journal><pubmed_title>PEGylation of indium phosphide quantum dots prevents quantum dot mediated platelet activation.</pubmed_title><pmcid>PMC11619005</pmcid><funding_grant_id>MR/T002573/1</funding_grant_id><funding_grant_id>FS/PhD/22/29265</funding_grant_id><pubmed_authors>Hondow N</pubmed_authors><pubmed_authors>Leonard SVL</pubmed_authors><pubmed_authors>Booth Z</pubmed_authors><pubmed_authors>Price TW</pubmed_authors><pubmed_authors>Stasiuk GJ</pubmed_authors><pubmed_authors>Chamberlain T</pubmed_authors><pubmed_authors>Naseem K</pubmed_authors><pubmed_authors>Schneider JE</pubmed_authors><pubmed_authors>Tung LD</pubmed_authors><pubmed_authors>Aslam Z</pubmed_authors><pubmed_authors>Allsup D</pubmed_authors><pubmed_authors>Harvell-Smith S</pubmed_authors><pubmed_authors>Calaminus SDJ</pubmed_authors><pubmed_authors>Thi Kim Thanh N</pubmed_authors><pubmed_authors>Naylor-Adamson L</pubmed_authors><pubmed_authors>Bouillard JG</pubmed_authors><pubmed_authors>Gallo J</pubmed_authors></additional><is_claimable>false</is_claimable><name>PEGylation of indium phosphide quantum dots prevents quantum dot mediated platelet activation.</name><description>Quantum dots (QDs) are semiconducting inorganic nanocrystals, that have garnered interest in biological and medical spheres due, to their potential benefits in biomedical imaging and drug-delivery systems. Indium phosphide QDs shelled with zinc sulphide (InP/ZnS) are viewed as more biocompatible than previous heavy metal based QDs. However, little is known about how InP/ZnS QDs affect a key blood cell, the platelet. Understanding how platelets interact with QDs is critical as unwanted activation can lead to pathological thrombus formation. Herein, we demonstrate PEGylation of InP/ZnS QDs coated with lipoic acid (QD-LA) or coated with penicillamine (QD-Pen) surface ligands induced markedly less platelet aggregation, platelet-QD interactions, integrin activation, alpha granule secretion and </description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jan</publication><modification>2025-04-04T02:35:16.26Z</modification><creation>2025-04-04T02:35:16.26Z</creation></dates><accession>S-EPMC11619005</accession><cross_references><pubmed>39635869</pubmed><doi>10.1039/d4tb01334d</doi></cross_references></HashMap>